Concord Biotech

Concord Biotech FCF per Share

The Free Cash Flow per Share of Concord Biotech (CONCORDBIO.NS) as of Oct 18, 2026 is 16.64 INR. In the previous year, Free Cash Flow per Share was 13.02 INR — a change of 27.81% (higher).

FCF per Share

16.64INR

YoY

27.81%

Last updated:

Free Cash Flow per Share of Concord Biotech is 2026 16.64 INR. Free Cash Flow per Share of Concord Biotech was 2025 13.02 INR. It decreases by 27.81% higher compared to the previous year.

The Concord Biotech FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2020
-0.06 INR
Jan 1, 2021
-3.57 INR
Jan 1, 2022
4.97 INR
Jan 1, 2023
9.64 INR
Jan 1, 2024
17.19 INR
Jan 1, 2025
13.02 INR
Jan 1, 2026
16.64 INR
The Concord Biotech FCF per Share history
YEARFCF per ShareYoY
16.64INR+27.81%
13.02INR-24.25%
17.19INR+78.34%
9.64INR+93.93%
4.97INR-239.20%
-3.57INR+5,896.63%
-0.06INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Concord Biotech Stock analysis

What does Concord Biotech do? Concord Biotech Ltd is a pharmaceutical company headquartered in Ahmedabad, India. It operates in the Health Care sector with a focus on Pharmaceuticals. The company went public via an IPO on August 18, 2023. Concord Biotech develops and manufactures active pharmaceutical ingredients (APIs) using fermentation and semi-synthetic processes. It produces finished formulations and APIs for therapeutic areas including immunosuppressants, anti-bacterial, oncology, and anti-fungal treatments. The company's API portfolio includes Mycophenolate Mofetil, Cyclosporine, Vancomycin Hydrochloride, and others. It also has a pipeline of API products under development such as Polymyxin B and Fidaxomicin. Concord Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Concord Biotech stock

Free Cash Flow per Share of Concord Biotech is 16.64 INR in 2026.

Free Cash Flow per Share of Concord Biotech changed from 13.02 INR to 16.64 INR, representing a 27.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Concord Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Concord Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Concord Biotech